Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - CASH FROM OPERATIONS
Cash from Operations NBIX - Neurocrine Biosciences, Inc.
595 M
LAST VALUE
32.45%
2 YEAR CAGR
31.39%
5 YEAR CAGR
30.78%
10 YEAR CAGR